Hürthle cell carcinoma in a patient with Graves' Disease.
Hürthle cell, a rare form of thyroid carcinoma, has been reported only five times in patients with Grave's Disease. We present a case report and comprehensive review of the literature. Surgery should be considered in patients with both Graves' Disease and an expanding goiter. Initial high-dose radioiodine should be administered post-operatively in patients with Hürthle cell carcinoma. Serum thyroglobulin and 18-FDG total body PET imaging may be valuable in discovering residual or recurrent disease.
Carmichael
Kim A
KA
Division of Endocrinology, Metabolism and Lipid Research, Department of Internal Medicine, Washington University School of Medicine, USA. kcarmich@dom.wustl.edu
D018249:Adenoma, Oxyphilic / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D005260:Female; D006111:Graves Disease / Q000150:complications*; D006801:Humans; D008875:Middle Aged; D013964:Thyroid Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000628:therapy